Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
Investigators aimed to evaluate efficacy and safety of early Initiation of evolocumab and
combination lipid-lowering agent (statin + Ezetimibe) on lipid profiles changes in patients
with ACS undergoing PCI